Effector (biology)

Last updated

Example of a Serrate RNA effector molecule Serrate rna effector molecule.png
Example of a Serrate RNA effector molecule

In biology, an effector is a general term that can refer to several types of molecules or cells. In the context of biological system regulation, an effector is an element of a regulation loop controlling a regulated quantity. [1]

Small molecule effectors

Protein effectors

RNA effectors

Effector cells

Types

Related Research Articles

<span class="mw-page-title-main">Antigen</span> Molecule triggering an immune response (antibody production) in the host

In immunology, an antigen (Ag) is a molecule, moiety, foreign particulate matter, or an allergen, such as pollen, that can bind to a specific antibody or T-cell receptor. The presence of antigens in the body may trigger an immune response.

<span class="mw-page-title-main">Hemoglobin</span> Metalloprotein that binds with oxygen

Hemoglobin is a protein containing iron that facilitates the transportation of oxygen in red blood cells. Almost all vertebrates contain hemoglobin, with the sole exception of the fish family Channichthyidae. Hemoglobin in the blood carries oxygen from the respiratory organs to the other tissues of the body, where it releases the oxygen to enable aerobic respiration which powers an animal's metabolism. A healthy human has 12 to 20 grams of hemoglobin in every 100 mL of blood. Hemoglobin is a metalloprotein, a chromoprotein, and globulin.

<span class="mw-page-title-main">Immune system</span> Biological system protecting an organism against disease

The immune system is a network of biological systems that protects an organism from diseases. It detects and responds to a wide variety of pathogens, from viruses to bacteria, as well as cancer cells, parasitic worms, and also objects such as wood splinters, distinguishing them from the organism's own healthy tissue. Many species have two major subsystems of the immune system. The innate immune system provides a preconfigured response to broad groups of situations and stimuli. The adaptive immune system provides a tailored response to each stimulus by learning to recognize molecules it has previously encountered. Both use molecules and cells to perform their functions.

<span class="mw-page-title-main">Vesicle (biology and chemistry)</span> Any small, fluid-filled, spherical organelle enclosed by a membrane

In cell biology, a vesicle is a structure within or outside a cell, consisting of liquid or cytoplasm enclosed by a lipid bilayer. Vesicles form naturally during the processes of secretion (exocytosis), uptake (endocytosis), and the transport of materials within the plasma membrane. Alternatively, they may be prepared artificially, in which case they are called liposomes. If there is only one phospholipid bilayer, the vesicles are called unilamellar liposomes; otherwise they are called multilamellar liposomes. The membrane enclosing the vesicle is also a lamellar phase, similar to that of the plasma membrane, and intracellular vesicles can fuse with the plasma membrane to release their contents outside the cell. Vesicles can also fuse with other organelles within the cell. A vesicle released from the cell is known as an extracellular vesicle.

<span class="mw-page-title-main">Exocytosis</span> Active transport and bulk transport in which a cell transports molecules out of the cell

Exocytosis is a form of active transport and bulk transport in which a cell transports molecules out of the cell. As an active transport mechanism, exocytosis requires the use of energy to transport material. Exocytosis and its counterpart, endocytosis, are used by all cells because most chemical substances important to them are large polar molecules that cannot pass through the hydrophobic portion of the cell membrane by passive means. Exocytosis is the process by which a large amount of molecules are released; thus it is a form of bulk transport. Exocytosis occurs via secretory portals at the cell plasma membrane called porosomes. Porosomes are permanent cup-shaped lipoprotein structures at the cell plasma membrane, where secretory vesicles transiently dock and fuse to release intra-vesicular contents from the cell.

<span class="mw-page-title-main">Hemoprotein</span> Protein containing a heme prosthetic group

A hemeprotein, or heme protein, is a protein that contains a heme prosthetic group. They are a very large class of metalloproteins. The heme group confers functionality, which can include oxygen carrying, oxygen reduction, electron transfer, and other processes. Heme is bound to the protein either covalently or noncovalently or both.

<span class="mw-page-title-main">Allosteric regulation</span> Regulation of enzyme activity

In the fields of biochemistry and pharmacology an allosteric regulator is a substance that binds to a site on an enzyme or receptor distinct from the active site, resulting in a conformational change that alters the protein's activity, either enhancing or inhibiting its function. In contrast, substances that bind directly to an enzyme's active site or the binding site of the endogenous ligand of a receptor are called orthosteric regulators or modulators.

<span class="mw-page-title-main">Riboswitch</span>

In molecular biology, a riboswitch is a regulatory segment of a messenger RNA molecule that binds a small molecule, resulting in a change in production of the proteins encoded by the mRNA. Thus, an mRNA that contains a riboswitch is directly involved in regulating its own activity, in response to the concentrations of its effector molecule. The discovery that modern organisms use RNA to bind small molecules, and discriminate against closely related analogs, expanded the known natural capabilities of RNA beyond its ability to code for proteins, catalyze reactions, or to bind other RNA or protein macromolecules.

<span class="mw-page-title-main">Binding site</span> Molecule-specific coordinate bonding area in biological systems

In biochemistry and molecular biology, a binding site is a region on a macromolecule such as a protein that binds to another molecule with specificity. The binding partner of the macromolecule is often referred to as a ligand. Ligands may include other proteins, enzyme substrates, second messengers, hormones, or allosteric modulators. The binding event is often, but not always, accompanied by a conformational change that alters the protein's function. Binding to protein binding sites is most often reversible, but can also be covalent reversible or irreversible.

<span class="mw-page-title-main">Adaptive immune system</span> Subsystem of the immune system

The adaptive immune system, AIS, also known as the acquired immune system, or specific immune system is a subsystem of the immune system that is composed of specialized cells, organs, and processes that eliminate pathogens specifically. The acquired immune system is one of the two main immunity strategies found in vertebrates.

<span class="mw-page-title-main">Innate immune system</span> Immunity strategy in living beings

The innate immune system or nonspecific immune system is one of the two main immunity strategies in vertebrates. The innate immune system is an alternate defense strategy and is the dominant immune system response found in plants, fungi, prokaryotes, and invertebrates.

<span class="mw-page-title-main">Human iron metabolism</span> Iron metabolism in the body

Human iron metabolism is the set of chemical reactions that maintain human homeostasis of iron at the systemic and cellular level. Iron is both necessary to the body and potentially toxic. Controlling iron levels in the body is a critically important part of many aspects of human health and disease. Hematologists have been especially interested in systemic iron metabolism, because iron is essential for red blood cells, where most of the human body's iron is contained. Understanding iron metabolism is also important for understanding diseases of iron overload, such as hereditary hemochromatosis, and iron deficiency, such as iron-deficiency anemia.

In biology, cell signaling is the process by which a cell interacts with itself, other cells, and the environment. Cell signaling is a fundamental property of all cellular life in prokaryotes and eukaryotes.

Host tropism is the infection specificity of certain pathogens to particular hosts and host tissues. This explains why most pathogens are only capable of infecting a limited range of host organisms.

<span class="mw-page-title-main">Cobalamin riboswitch</span> RNA family

Cobalamin riboswitch is a cis-regulatory element which is widely distributed in 5' untranslated regions of vitamin B12 (Cobalamin) related genes in bacteria.

Resistance genes (R-Genes) are genes in plant genomes that convey plant disease resistance against pathogens by producing R proteins. The main class of R-genes consist of a nucleotide binding domain (NB) and a leucine rich repeat (LRR) domain(s) and are often referred to as (NB-LRR) R-genes or NLRs. Generally, the NB domain binds either ATP/ADP or GTP/GDP. The LRR domain is often involved in protein-protein interactions as well as ligand binding. NB-LRR R-genes can be further subdivided into toll interleukin 1 receptor (TIR-NB-LRR) and coiled-coil (CC-NB-LRR).

<span class="mw-page-title-main">Plant disease resistance</span> Ability of plants to withstand pathogens

Plant disease resistance protects plants from pathogens in two ways: by pre-formed structures and chemicals, and by infection-induced responses of the immune system. Relative to a susceptible plant, disease resistance is the reduction of pathogen growth on or in the plant, while the term disease tolerance describes plants that exhibit little disease damage despite substantial pathogen levels. Disease outcome is determined by the three-way interaction of the pathogen, the plant, and the environmental conditions.

In plant biology, elicitors are extrinsic or foreign molecules often associated with plant pests, diseases or synergistic organisms. Elicitor molecules can attach to special receptor proteins located on plant cell membranes. These receptors are able to recognize the molecular pattern of elicitors and trigger intracellular defence signalling via the octadecanoid pathway. This response results in the enhanced synthesis of metabolites which reduce damage and increase resistance to pest, disease or environmental stress. This is an immune response called pattern triggered immunity (PTI).

<span class="mw-page-title-main">Type VI secretion system</span> Bacterial molecular machine

The type VI secretion system (T6SS) is one of the bacterial secretion systems, membrane protein complexes, used by a wide range of gram-negative bacteria to transport effectors. Effectors are moved from the interior of a bacterial cell, across the membrane into an adjacent target cell. While often reported that the T6SS was discovered in 2006 by researchers studying the causative agent of cholera, Vibrio cholerae, the first study demonstrating that T6SS genes encode a protein export apparatus was actually published in 2004, in a study of protein secretion by the fish pathogen Edwardsiella tarda.

Contact-dependent growth inhibition (CDI) is a phenomenon where a bacterial cell may deliver a polymorphic toxin molecule into neighbouring bacterial cells upon direct cell-cell contact, causing growth arrest or cell death.

References

  1. Konieczny, Leszek; Roterman-Konieczna, Irena; Spólnik, Paweł (2023), "Regulation in Biological Systems", Systems Biology, Cham: Springer International Publishing, pp. 159–203, doi:10.1007/978-3-031-31557-2_4, ISBN   978-3-031-31556-5 , retrieved 2025-02-04
  2. Takayanagi, Masayoshi; Kurisaki, Ikuo; Nagaoka, Masataka (2014-04-08). "Non-site-specific allosteric effect of oxygen on human hemoglobin under high oxygen partial pressure". Scientific Reports. 4 (1): 4601. Bibcode:2014NatSR...4E4601T. doi:10.1038/srep04601. ISSN   2045-2322. PMC   3978498 . PMID   24710521.
  3. Artsimovitch, Irina; Vassylyeva, Marina N.; Svetlov, Dmitri; Svetlov, Vladimir; Perederina, Anna; Igarashi, Noriyuki; Matsugaki, Naohiro; Wakatsuki, Soichi; Tahirov, Tahir H.; Vassylyev, Dmitry G. (2005-08-12). "Allosteric Modulation of the RNA Polymerase Catalytic Reaction Is an Essential Component of Transcription Control by Rifamycins". Cell. 122 (3): 351–363. doi: 10.1016/j.cell.2005.07.014 . ISSN   0092-8674. PMID   16096056. S2CID   8237649.
  4. Garst, A. D.; Edwards, A. L.; Batey, R. T. (2011-06-01). "Riboswitches: Structures and Mechanisms". Cold Spring Harbor Perspectives in Biology. 3 (6): a003533. doi:10.1101/cshperspect.a003533. ISSN   1943-0264. PMC   3098680 . PMID   20943759.
  5. Mulhbacher, Jérôme; Lafontaine, Daniel A. (August 2007). "Ligand recognition determinants of guanine riboswitches". Nucleic Acids Research. 35 (16): 5568–5580. doi:10.1093/nar/gkm572. ISSN   1362-4962. PMC   2018637 . PMID   17704135.
  6. Kiel, Christina; Matallanas, David; Kolch, Walter (2021). "The Ins and Outs of RAS Effector Complexes". Biomolecules. 11 (2): 236. doi: 10.3390/biom11020236 . PMC   7915224 . PMID   33562401.
  7. Tendler, Avichai; Bar, Alon; Mendelsohn-Cohen, Netta; Karin, Omer; Kohanim, Yael Korem; Maimon, Lior; Milo, Tomer; Raz, Moriya; Mayo, Avi; Tana, Amos; Uri, Alon (2021-09-15). "Hormone seasonality in medical records suggests circannual endocrine circuits". Yearbook of Paediatric Endocrinology. 118 (7). doi:10.1530/ey.18.15.12. ISSN   1662-4009. PMC   7896322 . PMID   33531344.
  8. Oostindie SC, Lazar GA, Schuurman J, Parren PW (October 2022). "Avidity in antibody effector functions and biotherapeutic drug design". Nature Reviews. Drug Discovery. 21 (10): 715–735. doi:10.1038/s41573-022-00501-8. PMC   9255845 . PMID   35790857.
  9. Wagner S, Grin I, Malmsheimer S, Singh N, Torres-Vargas CE, Westerhausen S (October 2018). "Bacterial type III secretion systems: a complex device for the delivery of bacterial effector proteins into eukaryotic host cells". FEMS Microbiology Letters. 365 (19). doi:10.1093/femsle/fny201. PMC   6140923 . PMID   30107569.
  10. Strauß, Tina; van Poecke, Remco M. P.; Strauß, Annett; Römer, Patrick; Minsavage, Gerald V.; Singh, Sylvia; Wolf, Christina; Strauß, Axel; Kim, Seungill; Lee, Hyun-Ah; Yeom, Seon-In; Parniske, Martin; Stall, Robert E.; Jones, Jeffrey B.; Choi, Doil (2012-11-20). "RNA-seq pinpoints a Xanthomonas TAL-effector activated resistance gene in a large-crop genome". Proceedings of the National Academy of Sciences. 109 (47): 19480–19485. Bibcode:2012PNAS..10919480S. doi: 10.1073/pnas.1212415109 . ISSN   0027-8424. PMC   3511116 . PMID   23132937.
  11. Steinberg G (March 2007). "Hyphal growth: a tale of motors, lipids, and the Spitzenkörper". Eukaryotic Cell. 6 (3): 351–360. doi:10.1128/EC.00381-06. PMC   1828937 . PMID   17259546.
  12. Wang, Ming; Weiberg, Arne; Jin, Hailing (April 2015). "Pathogen small RNAs: a new class of effectors for pathogen attacks: Pathogen small RNAs at attack". Molecular Plant Pathology. 16 (3): 219–223. doi:10.1111/mpp.12233. PMC   6638317 . PMID   25764211.
  13. Arnone, Baron; Zhao, Xiaoqi; Zou, Zhipeng; Qin, Gangjian; Cheng, Min (2015-01-01), Tang, Yaoliang; Dawn, Buddhadeb (eds.), "Chapter 11 - Diagnostic and Prognostic Applications of MicroRNA-Abundant Circulating Exosomes", Mesenchymal Stem Cell Derived Exosomes, Boston: Academic Press, pp. 223–256, doi:10.1016/b978-0-12-800164-6.00011-3, ISBN   978-0-12-800164-6 , retrieved 2023-01-18
  14. Baron, Mark; Vaso, Kristina; Avigdor, Tamir; Charit, Yelena; Minert, Anne; Devor, Marshall (2022-11-01). "Anesthetic loss of consciousness induced by chemogenetic excitation of mesopontine effector neurons". Experimental Neurology. 357: 114169. doi:10.1016/j.expneurol.2022.114169. ISSN   0014-4886. PMID   35817130. S2CID   250361680.